Cision PR Newswire APAC
pressCenter
Transpire Bio to Participate in Upcoming Healthcare Investor Conferences During Septembertranslating…
SUNRISE, Fla., Sept. 2, 2026 /PRNewswire/ -- Transpire Bio, a U.S.-based clinical-stage, biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that members of its executive leadership team will participate in…
Keywords#Transpire Bio#Participate#Conferences#Conferences During#Conferences During September
Comments
Sign in to join the discussion.
Loading comments…